cisapride and glycerol

cisapride has been researched along with glycerol in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Gong, Q; January, CT; Zhou, Z1
Correa, GI; Rotter, KP1

Other Studies

3 other study(ies) available for cisapride and glycerol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects.
    The Journal of biological chemistry, 1999, Oct-29, Volume: 274, Issue:44

    Topics: Anti-Arrhythmia Agents; Astemizole; Biological Transport; Cation Transport Proteins; Cell Compartmentation; Cisapride; DNA-Binding Proteins; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Glycerol; Humans; Long QT Syndrome; Mutation; Patch-Clamp Techniques; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Folding; Pyridines; Recombinant Proteins; Temperature; Trans-Activators; Transcriptional Regulator ERG

1999
Clinical evaluation and management of neurogenic bowel after spinal cord injury.
    Spinal cord, 2000, Volume: 38, Issue:5

    Topics: Adult; Cisapride; Colonic Diseases; Dietary Fiber; Dioctyl Sulfosuccinic Acid; Female; Gastrointestinal Agents; Gastrointestinal Transit; Glycerol; Humans; Intestinal Diseases; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Spinal Cord Injuries; Suppositories; Surface-Active Agents; Treatment Outcome

2000